Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 525 (ZNF525) is a member of the large zinc finger protein family, characterized by the presence of zinc finger domains that enable DNA binding and transcriptional regulatory activity[1][2][4]. ZNF525 is predicted to function as a DNA-binding transcription factor, likely involved in modulating gene expression through sequence-specific interactions with DNA and potentially influencing transcription by RNA polymerase II[4]. Its canonical localization is nuclear. While the biological function of ZNF525 is not comprehensively mapped, expression signature studies identify it as part of a gene panel with prognostic significance in osteosarcoma, suggesting its expression pattern may contribute to cancer risk stratification rather than direct therapeutic targeting[3]. No direct drug interactions, therapeutic mechanisms of action, or specific safety issues are known for this target to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 525 (ZNF525).